Dr. Lecia Sequist: Can We Bring The Advances in Targeted Therapy to Squamous NSCLC and Broader NSCLC Populations?

Dr. Lecia Sequist: Can We Bring The Advances in Targeted Therapy to Squamous NSCLC and Broader NSCLC Populations?

Da: GRACEcast
0 0 7 anni fa
00:00
01:03
Medicina, #adenocarcinoma, #advanced, #cancergrace, #general, #grace, #gracecast, #histology, #hospital, #lecia, #marker, #markers, #massachusetts, #molecular, #mutation, #nsclc, #oncology, #squamous, #targeted, #testing, #therapies
Dr. Lecia Sequist provides her thoughts on how molecular oncology can soon begin affecting treatment plans for a broader range of patients with lung cancer, including those with squamous NSCLC and other lung cancer histologies.

Autore

cancerGRACE Meetings
cancerGRACE Meetings 2 followers Follow

Seguici su Facebook

Spreaker logo
  • Scegli una lingua

Per podcaster ed editori

Strumenti per i podcaster

Per gli ascoltatori

Copyright 2021 - Spreaker Inc. a Voxnest Company - Crea un podcast - New York, NY